Johnson & Johnson(JNJ)Stock Performance & ReturnsNYSE
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
JNJ | 625.03 B | 29.44x | 5.90% | 16.20% | $8.81 | - | 0.58x | 0.51% | $281.07 | $184.66 |
LLY | 1.14 T | 41.58x | 47.70% | 33.53% | $30.87 | 102.29% | 1.62x | 0.52% | $1292.65 | $778.94 |
ABBV | 510.84 B | 78.98x | 10.20% | 9.80% | $3.66 | - | - | 2.41% | $285.40 | $189.40 |
MRK | 365.88 B | 117.70x | 5.10% | 4.77% | $1.26 | 6.96% | 1.28x | 2.29% | $156.00 | $79.67 |
AZN | 261.82 B | 24.26x | 6.40% | 17.02% | $6.96 | 21.97% | 0.64x | 1.94% | $210.52 | $153.41 |
NVO | 131.36 B | 9.62x | 2.10% | 35.35% | $4.09 | 59.82% | 0.63x | 29.83% | $61.11 | $34.15 |
Peer Valuation & Performance Analysis
Peer group analysis for Johnson & Johnson (JNJ) compared to its primary competitors (including LLY, ABBV, MRK) reveals distinct metrics. JNJ trades at a valuation discount relative to its competitors, with a P/E ratio of 29.4x versus the peer average of 52.4x (representing a 44% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, JNJ's revenue growth of 5.9% lags behind the peer average of 12.5%, indicating potential market share losses or slower industry adoption. Additionally, its net margin of 16.2% is comparable to the peer average of 18.1%.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• JNJ ranks #2 in P/E ratio, #4 in revenue growth, and #3 in profit margins
• Average ranking: #3 - 📊 Solid financials relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-21 | $257.50 | $257.80 | $254.56 | $257.78 | 6,189,372 | -0.61% |
| 2026-10-20 | $257.48 | $260.77 | $256.42 | $259.36 | 7,659,800 | +2.19% |
| 2026-10-19 | $254.43 | $255.56 | $251.50 | $253.79 | 8,847,400 | -0.69% |
| 2026-10-16 | $255.52 | $257.55 | $254.00 | $255.56 | 6,548,000 | +0.90% |
| 2026-10-15 | $257.11 | $262.45 | $252.62 | $253.28 | 9,274,700 | -0.25% |
| 2026-10-14 | $249.10 | $253.94 | $248.50 | $253.91 | 9,662,000 | +2.13% |
| 2026-10-13 | $254.56 | $256.18 | $245.17 | $248.61 | 16,647,100 | -5.73% |
| 2026-10-12 | $261.60 | $264.39 | $260.37 | $263.73 | 5,902,500 | +0.88% |
| 2026-10-09 | $255.09 | $261.61 | $254.99 | $261.44 | 5,726,000 | +1.93% |
| 2026-10-08 | $256.22 | $257.80 | $251.95 | $256.48 | 6,172,800 | -0.76% |
| 2026-10-07 | $256.21 | $260.68 | $255.73 | $258.45 | 5,402,200 | +1.44% |
| 2026-10-06 | $254.15 | $255.48 | $251.17 | $254.78 | 5,661,000 | +0.73% |
| 2026-10-05 | $256.00 | $256.24 | $252.51 | $252.93 | 10,026,800 | -1.21% |
| 2026-10-02 | $259.38 | $259.38 | $255.12 | $256.03 | 10,940,400 | -1.02% |
| 2026-10-01 | $263.68 | $263.98 | $258.33 | $258.66 | 8,289,000 | -2.30% |
Explore More Analysis for JNJ
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.